Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

38,389 stories, page 270 of 640

Advanced search

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Can the FDA Keep Up With the Peptide Boom?

The Food InstituteOriginal source

🌍Aug 13Researchkemri.go.keTier 2 · Direct publisher

KEMRI Hosts Cochrane Kenya Review Jam to Strengthen Evidence-Based Research

KEMRI KenyaOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Humana agrees not to reference Teva's Israel ties at US drug trial

ReutersOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Louisville mom with Stage IV pancreatic cancer tries new drug as last hope | Exclusive

The Courier-JournalOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Global Health Summit 2026 highlights clinical translation and biotech investment in Hong Kong

BioSpectrum AsiaOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Maternal RSV vaccine halves newborn ICU admissions, says UKHSA

The Pharmaceutical JournalOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

FDA Approves Sagimet Biosciences' IND for Phase 3 Denifanstat Acne Study

Kalkine MediaOriginal source

🇺🇰Aug 13Regulatoryabpi.org.ukTier 1 · Regulatory source

New pre-clinical translational models hub to accelerate development of human-relevant models for medicines discovery

ABPI UKOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

UNACCOUNTABLE: Big Abortion breaks abortion pill rules, but no one seems to care

liveaction.orgOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

FDA Recalls and Warnings: Foreign Particles Found in Compounded Semaglutide, Cancer-Causing Impurities in Bladder Drug

MedShadow FoundationOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

The Biotech Growth Trust Delivers Strong One-year Gains, Significant Outperformance

DirectorsTalk InterviewsOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

JW Pharmaceutical gout drug shows superiority in phase 3 trial

Investing.comOriginal source

🌍Aug 13discoverynews.google.comTier 2 · Trade media

Neurocrine stands by blockbuster hopeful Vykat XR as Prader-Willi docs raise potential safety flags

Fierce PharmaOriginal source

🌍Aug 13discoverynews.google.comTier 2 · Trade media

Fierce Biotech Fundraising Tracker '26: InduPro assembles $77M; Vaderis nets $152M series B

fiercebiotech.comOriginal source

🇺🇸Aug 13Researchrarediseases.orgTier 2 · Direct publisher

NORD Statement in Response to HRSA National Newborn Screening Working Group Announcement

NORD Rare DiseasesOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

JW-PHARMACEUTICAL

Caledonian RecordOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

JW Pharmaceutical Proves Efficacy of Key 6mg Dose of Gout Treatment ‘Epaminurad’ in Multinational Phase 3 Trial

MorningstarOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Biotech initiatives pick up as more regions race to become hubs

Pharma VoiceOriginal source

🇺🇰Aug 13Regulatorygov.ukTier 1 · Regulatory source

UK Clinical Research Delivery key performance indicators: data to July 2026

Report bringing together data on the delivery of globally competitive clinical research through the...

UK Department of Health and Social CareOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Why is Collegium Pharmaceutical stock climbing today?

Investing.comOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

The Biotech Growth Trust PLC - Net Asset Value(s)

uk.finance.yahoo.comOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Collegium Pharmaceutical stock jumps on $50M share buyback

Investing.comOriginal source

🌍Aug 13discoverynews.google.comTier 2 · Trade media

After tasting IPO success, Hemab’s CEO seeks ‘flavor of a multi-product coagulation company’

Fierce BiotechOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Pace(R) Appoints Andy Fenny as President of Pace(R) Life Sciences to Drive Strategic Growth

newswire.comOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

JW Pharmaceutical Proves Efficacy of Key 6mg Dose of Gout Treatment ‘Epaminurad’ in Multinational Phase 3 Trial

Yahoo! Finance CanadaOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

PhenoNet Cleared by FDA to Begin Phase 3 Trial of Inhaled PHENOGENE-1A in Early Alzheimer's Disease

Business WireOriginal source

🌍Aug 13Researchanswers.childrenshospital.orgTier 2 · Direct publisher

‘We’re gonna start over’: Finding the right care for Remi’s aspiration

Boston Children's HospitalOriginal source

🌍Aug 13discoverynews.google.comTier 2 · Trade media

Pfizer’s former chemistry whiz debuts Khartis Therapeutics with $95M for thyroid eye disease pill

Fierce BiotechOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Collegium Pharmaceutical Launches $50 Million Accelerated Share Repurchase Program

citybizOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

PDS Biotech Reports $9.8 Million Second-Quarter 2026 Net Loss

Quiver QuantitativeOriginal source

🇧🇷Aug 13Industryems.com.brTier 1 · Company source

POLÍTICA DE PRIVACIDADE

EMS Pharma NewsOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

IYH vs. FBT: Broad Healthcare ETF or Concentrated Biotech Play?

The Motley FoolOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

IYH vs. FBT: Broad Healthcare ETF or Concentrated Biotech Play?

Yahoo FinanceOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Candel Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights

The Manila TimesOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

MeiraGTx Reports Second Quarter 2026 Financial and Operational Results

manilatimes.netOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Ascentage Pharma to Participate in the Evercore 2nd Annual China Biotech Summit

The Manila TimesOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Grace Therapeutics Announces First Quarter 2027 Financial Results, Provides Business Update

manilatimes.netOriginal source

🌍Aug 13discoverynews.google.comTier 2 · Trade media

PTC’s $211M bid wins Sangamo auction, teeing up ‘special opportunity’ to enter Fabry market

Fierce BiotechOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Candel Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights

GlobeNewswireOriginal source

🇺🇸Aug 13Industrytechcyte.comTier 1 · Company source

Techcyte and elea Bring AI-Native Pathology Reporting into Techcyte Fusion®

TechcyteOriginal source

🇨🇦Aug 13Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

Unauthorized injectable health products sold online and seized from Dyosa Beauty & Wellness Lounge in Hamilton, ON, may pose serious health risks

Health Canada has seized several unauthorized injectable health products—including counterfeit medic...

Health Canada Recalls and Safety AlertsOriginal source

🇨🇦Aug 13Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

Portrait Core Services Cssxb

GE HealthCare has become aware that during a service event to update Portrait Core Services software...

Health Canada Recalls and Safety AlertsOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Xanadu and University of Alberta Partner to Accelerate Pharmaceutical Discoveries with Quantum Computing

The Globe and MailOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

GCC expands pharmaceutical manufacturing as market surpasses $30 billion

Fast Company Middle EastOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Sagimet Wins FDA Clearance for Phase 3 Acne Trial

TipRanksOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

FDA clears Sagimet’s phase 3 trial for acne treatment denifanstat

Investing.comOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Collegium Pharmaceutical launches $50M accelerated share repurchase under $150M buyback program

TradingViewOriginal source

🌍Aug 13Industrynervgen.comTier 1 · Company source

NervGen Reports Second Quarter 2026 Financial Results and Provides Business Updates

NervGen PharmaOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Karyopharm Reports Second Quarter 2026 Financial Results and Highlights Continued Progress Toward Myelofibrosis sNDA Submission

TradingViewOriginal source

🇺🇸Aug 13Industryinvestors.abeonatherapeutics.comTier 1 · Company source

Abeona Therapeutics® Reports Second Quarter 2026 Results and Provides Business Update

Abeona TherapeuticsOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Sagimet Biosciences Phase 3 Clinical Trial Is On Track To Initiate In Second Half Of 2026

TradingViewOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Insider Selling: Takeda Pharmaceutical (NYSE:TAK) Insider Sells $239,502.60 in Stock

MarketBeatOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA suspends four Domino's outlets after hygiene violations

India TodayOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Zenas BioPharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update

manilatimes.netOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

FDA clears Sagimet Biosciences to begin Phase 3 trial of denifanstat for acne

Investing.comOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Sagimet Biosciences Announces FDA Clearance of IND for Phase 3 Denifanstat Acne Trial

Quiver QuantitativeOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Sagimet Plans Acne Trial With About 800 Patients, 450 Expected Adolescents

Stock TitanOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

Senoia Rotary Club Provides Safe Pharmaceutical Disposal Kiosk to the Community

TheCitizen.comOriginal source

🌍Aug 13discoverynews.google.comTier 3 · Aggregated media

West Pharmaceutical Services, Inc. $WST Stock Position Reduced by Handelsbanken Fonder AB

MarketBeatOriginal source

🌍Aug 13discoverynews.google.comTier 2 · Trade media

Neurocrine Biosciences and the delicate balance of benefit and risk

STATOriginal source